Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.

You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings



Grünenthal – innovating to improve lives

We are skilled entrepreneurs and scientists working together to develop new solutions for patients suffering from pain-related diseases and adjacent conditions.

We combine our internal R&D capabilities with a collaborative network approach to ensure success. Patients are central in the journey towards developing effective pain solutions. Through our work with patient organisations and direct interaction with patients, we have been able to create tangible improved outcomes for patients.
Gabriel Baertschi, Chief Executive Officer (CEO) Grünenthal

Gabriel Baertschi, Chief Executive Officer

“Innovation is at the heart of everything that we do. It’s the driving force behind new ideas and future therapies. Innovation is more than just the development of new medications. It’s about expanding our knowledge, exploring new and different treatment approaches, exploiting technologies and harnessing big data. We want to improve patients’ lives. That’s why we continually seek opportunities to innovate.”

Gabriel Baertschi

Chief Executive Officer, Grünenthal

Filling our pipeline with innovations

Our R&D pipeline is a source of great excitement – we currently have several new drug candidates in different phases of development.
... Explore

Our focus

Our passion for innovation touches all that we do

We constantly strive for best-in-class solutions for our patients

Commit­ment to R&D

We constantly strive for best-in-class solutions for our patients by investing in our own R&D and building global scientific networks.

Grünenthal Campus Aachen, Germany

Broad in-house competence

We have R&D capabilities that span from idea generation to the launch of innovative therapies.

Positive creative man presenting a report

Intern­ational focus

Our innovation is truly global. Our worldwide collaborations enable patients around the world to experience the benefits of our R&D efforts and innovations.

Close up of a Synapse

The R&D engine

R&D enables us to meet our business goals by delivering innovative solutions to patients.

Combining forces

We are proud of our fully integrated  R&D infrastructure and the capabilities we have to bring a product from early development  to market. Still, there are some things we cannot  do alone - so we are constantly looking for Partners to collaborate on promising new development projects.

... Explore Partnering